Frontiers in Cellular and Infection Microbiology · 2021 · 12 citations · 21 references
Life SciencesImmunologyMicrobiologyImmunizationMucosal ImmunologyVaccinologyAdaptive Immunity To ParasitesHost-parasite Immune InteractionsMucosal ImmunizationMucosal VaccinesParasitic Disease PathogenesisT-cell Responses To ParasitesAnimal ImmunizationAntigen-specific Antibody ResponsesMucosal Vaccine EfficacyMucosal Vaccine ResponsesParasitic Infection ImmunityRecombinant Mucosal VaccinesSystemic Immune ResponseSystemic Immunity Against Pathogens
Pathogens require physical contact with the mucosal surface of the host organism to initiate infection and as such, vaccines eliciting both mucosal and systemic immune responses would be promising. Studies involving the use of recombinant baculoviruses (rBVs) as mucosal vaccines are severely lacking despite their inherently safe nature, especially against pathogens of global importance such as Toxoplasma gondii . Here, we generated rBVs displaying T. gondii rhoptry protein 4 (ROP4) and evaluated their protective efficacy in BALB/c mice following immunization via intranasal (IN) and oral routes. IN immunization with the ROP4-expressing rBVs elicited higher levels of parasite-specific IgA antibody responses compared to oral immunization. Upon challenge infection with a lethal dose of T. gondii ME49, IN immunization elicited significantly higher parasite-specific antibody responses in the mucosal tissues such as intestines, feces, vaginal samples, and brain than oral immunization. Marked increases in IgG and IgA antibody-secreting cell (ASC) responses were observed from intranasally immunized mice. IN immunization elicited significantly enhanced induction of CD4 + , CD8 + T cells, and germinal center B (GC B) cell responses from secondary lymphoid organs while limiting the production of the inflammatory cytokines IFN-γ and IL-6 in the brain, all of which contributed to protecting mice against T. gondii lethal challenge infection. Our findings suggest that IN delivery of ROP4 rBVs induced better mucosal and systemic immunity against the lethal T. gondii challenge infection compared to oral immunization.
21
ROP18 Is a Rhoptry Kinase Controlling the Intracellular Proliferation of Toxoplasma gondii
Hiba El Hajj, Maryse Lebrun, Stefan T. Arold et al. · PLoS Pathogens · 2007 · 210 citations · Full text
Robert Strauss, Andreas Hüser, Shaoheng Ni et al. · Molecular Therapy · 2006 · 131 citations · Full text
Efficient gene delivery into cell lines and stem cells using baculovirus
Li-Yu Sung, Chiu-Ling Chen, Shih-Yeh Lin et al. · Nature Protocols · 2014 · 94 citations